moxifloxacin has been researched along with mavoglurant in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (mavoglurant) | Trials (mavoglurant) | Recent Studies (post-2010) (mavoglurant) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 36 | 11 | 36 |
| Protein | Taxonomy | moxifloxacin (IC50) | mavoglurant (IC50) |
|---|---|---|---|
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | 0.0516 | |
| Metabotropic glutamate receptor 5 | Homo sapiens (human) | 0.0408 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodman, A; Ganesan, S; Jordaan, P; Legangneux, E; Sagkriotis, A; Salunke, A; Tisserant, A; Ufer, M; Voltz, E; Woessner, R | 1 |
1 trial(s) available for moxifloxacin and mavoglurant
| Article | Year |
|---|---|
Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056).
Topics: Administration, Intravenous; Adult; Allosteric Regulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Heart; Heart Conduction System; Humans; Indoles; Male; Moxifloxacin; Pilot Projects; Receptor, Metabotropic Glutamate 5 | 2016 |